Advertisement
News
Subscribe to MDT Magazine News

AultCare/Cardiocom® White Paper Shows Telehealth Services Reduce ER Visits and Inpatient Stays for Patients

September 13, 2010 4:32 am | by Bio-Medicine.Org | Comments

CANTON, Ohio, Sept. 13 /- AultCare has been using patient telemonitoring for six years and has, in partnership with Cardiocom, released a white paper entitled, "AultCare Sees Positive Results from Cardiocom Program." The paper describes the structure of the coordinated program between...

TOPICS:

Debiopharm Group™ and Aurigene Nominate Development Candidate

September 13, 2010 12:33 am | by Bio-Medicine.Org | Comments

LAUSANNE, Switzerland, and BANGALORE, India, Sept. 13 /- Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies...

TOPICS:

CareFusion Launches Spinal Treatment Device

September 12, 2010 11:31 pm | by San Diego Business Journal | Comments

CareFusion Corp., a medical technology company based in San Diego, has launched the AVAmax Vertebral Balloon, a device designed to improve and reduce the costs of kyphoplasty, a treatment for spinal compression fractures.

TOPICS:
Advertisement

Cancer deaths fall, but prevention still lags behind

September 12, 2010 10:34 pm | by EurekAlert | Comments

(ECCO-the European CanCer Organisation) Although overall mortality from cancer is decreasing in the European Union, its incidence increased by almost 20 percent, from 2.1 million new cases in 2002 to 2.5 million in 2008, says a special issue of the European Journal of Cancer (the...

TOPICS:

Early prostate cancer detection, screening: No benefit for men with low baseline PSA value

September 12, 2010 10:34 pm | by EurekAlert | Comments

(Wiley-Blackwell) Men aged 55-74 years who have low baseline blood levels of prostate specific antigen (PSA) are not likely to benefit from further screening and treatment. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the...

TOPICS:

Pushing ions through carbon nanotubes

September 12, 2010 10:33 pm | by I-Micronews | Comments

The tiny, multitalented carbon tubes can carry single molecules, one at a time.

Wheelchair Makes the Most of Brain Control

September 12, 2010 8:32 pm | by Massachusetts Institute of Technology | Comments

Artificial intelligence improves a wheelchair system that could give paralyzed people greater mobility.

TOPICS:

Gene discovery could yield treatments for nearsightedness

September 12, 2010 11:32 am | by EurekAlert | Comments

(Duke University Medical Center) Myopia (nearsightedness) is the most common eye disorder in the world and becoming more common, yet little is known about its genetic underpinnings. Scientists at Duke University Medical Center, in conjunction with several other groups, have...

TOPICS:
Advertisement

Free Dog Heart Checks at McAllister Park

September 11, 2010 4:35 pm | by Bio-Medicine.Org | Comments

SAN ANTONIO, Sept. 11 /- The Mobile Dog Heart Health Tour is heading south to San Antonio, Texas, for an afternoon of free heart health examinations in San Antonio's McAllister Dog Park. From 3 p.m. to 8 p.m. on September 17, certified veterinary cardiologists will be performing on site...

TOPICS:

Covidien Supports FDA's Patient Safety Efforts for Gadolinium-Based Contrast Agents

September 10, 2010 5:36 pm | by Covidien | Comments

ST. LOUIS, Sep 10, 2010 (BUSINESS WIRE) --Covidien (NYSE:COV), a leading global provider of healthcare products, today announced it supports the U.S. Food and Drug Administration's (FDA) labeling changes for gadolinium-based contrast agents for patients with acute kidney injury or...

TOPICS:

3M begins tender offer for Cogent shares

September 10, 2010 4:45 pm | by The Associated Press | Comments

3M Co., which makes Post-Its and various other products, said Friday it has begun a tender offer for all outstanding shares of security device developer Cogent Inc. at $10.50 a share.3M agreed to buy Cogent last month for about $943 million in a bid to expand into the security market.The board...

Covance to Present at Morgan Stanley Global Healthcare Conference

September 10, 2010 1:36 pm | by Bio-Medicine.Org | Comments

PRINCETON, N.J., Sept. 10 /- Covance Inc. (NYSE: CVD ) today announced that it will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 14, 2010 at 2:10 p.m. ET.  Investors may access a live webcast of the presentation at www.covance.com .  In order...

TOPICS:

FDA Approves New Dosing for FASLODEX® (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women

September 10, 2010 1:36 pm | by Bio-Medicine.Org | Comments

WILMINGTON, Del., Sept. 10 /- AstraZeneca (NYSE: AZN ) today announced that the U.S. Food and Drug Administration (FDA) has approved the 500mg dose of FASLODEX® (fulvestrant) Injection , replacing the previously approved monthly dose of 250mg, for the treatment of hormone...

TOPICS:

SME Announces 2011 Election Results for International Directors and Member Council

September 10, 2010 11:33 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., September 9, 2010 — The Society of Manufacturing Engineers (SME) announces the election of six new members to its Board of Directors and four new members to its Member Council for the 2011-12 term; one individual was also elected to serve a one-year term as an...

Hospira Symbiq One-Channel and Two-Channel Infusers: Class I Recall

September 10, 2010 11:33 am | by U.S. Food & Drug Administration | Comments

Potential for the device to fail to detect air in line at the end of an infusion.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading